Publication | Open Access

Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide

UrologyOncologyAbiraterone AcetateMedicinePharmacotherapyAnti-cancer AgentCancer TreatmentProstatic DiseasePharmacologyClinical Activity